MORE►
GLP-1 drugs
knownwell headquarters and clinic in Boston. [Photo: knownwell]
Co-Founded by a Dallas Native, Boston Metabolic Health Startup knownwell To Open Clinic in Plano
by David Seeley | Jun 24, 2024
knownwell was co-founded by CEO Brooke Boyarsky Pratt in 2022 to "lead a shift in the narrative from health systems, payors, and employers having a GLP-1 strategy, to them having a comprehensive obesity treatment strategy." With a recent $20 million Series A, new C-suite hires, and an AI-powered acquisition just last week, the startup's expansion has just begun.
by Quincy Preston |
Jan 19, 2024
“GLP-1 drugs, medications like Ozempic and other weight-loss drugs that are actually diabetes drugs, provide me with retail insights,” said Pil, according to a takeaway featured in D CEO. “We can look through Chase’s anonymized data by individual—we bank more than 95 million individuals in this country—and I can identify people who are on Ozempic based on their spending patterns."
MORE►
